Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01864174 · ClinicalTrials.gov registry record · Phase 4
Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes
A Phase 4 study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,736
- Enrollment target
NCT01864174: Completed Phase 4 study, sponsored by Bristol-Myers Squibb.
NCT01864174 is a Phase 4 study that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 1,736 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (235% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01864174, a Phase 4 study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,736 participants
- Enrollment target
Study Summary
The purpose of this study is determine if Metformin XR monotherapy in subjects with type 2 diabetes is non-inferior to Metformin IR monotherapy
Primary Outcome
Mean change in glycated hemoglobin (HbA1c) from baseline to Week 24 in the double-blind treatment period.
Interventions
- DRUG Metformin XR
- DRUG Metformin IR
- DRUG Placebo matching with Metformin XR
- DRUG Placebo matching with Metformin IR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,736 participants |
| Start Date | 2013-06-20 |
| Est. Completion | 2016-06-01 |
| Phase | Phase 4 |
What the finished NCT01864174 record still lists
NCT01864174 is an interventional study that assigns participants to a tested intervention. Its 1,736 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (235% higher).
The record links to 0 conditions, and to 4 interventions - of which Metformin XR is the first listed.
NCT01864174 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01864174 about?
NCT01864174 is a clinical study titled "Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes". The purpose of this study is determine if Metformin XR monotherapy in subjects with type 2 diabetes is non-inferior to Metformin IR monotherapy
What is the current status of trial NCT01864174?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,736 participants. The study started on 2013-06-20. Estimated completion is 2016-06-01.
What interventions are being tested in trial NCT01864174?
The interventions under investigation include: Metformin XR (DRUG), Metformin IR (DRUG), Placebo matching with Metformin XR (DRUG), Placebo matching with Metformin IR (DRUG).
Who is sponsoring clinical trial NCT01864174?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01864174's enrollment target sits among peer trials
1,736 45th of 2000 higher than 1,956 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04712656 · 1,739 participants
Effects of CPAP Therapy on Blood Pressure and Heart Rate Variability in Obstructive Sleep Apnea
- NCT06413420 · 1,731 participants
SUNOSI® (Solriamfetol) Pregnancy Registry
- NCT06898034 · 1,725 participants
Postpartum Ultrasound Evaluation to Assess Risk of Hemorrhage
- NCT05934487 · 1,750 participants · NA
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI